Visionable Appoints First CCO Following Rapid Growth in 2020

VisionableBritish health technology company Visionable has announced the appointment of David Walker to the newly created position of Chief Commercial Officer (CCO), effective immediately. Visionable redesigns healthcare through a digital collaboration platform which enables clinicians to deliver better patient outcomes.

The expansion of the business’ Executive Leadership team follows Visionable’s rapid growth in 2020, which saw £17 million of investment that the company raised in Series A and Series A1 funding rounds.

Visionable has appointed Walker to capitalise on its existing success. The company’s first CCO, Walker will be responsible for developing and creating new partnerships with international organisations to expand Visionable's presence in thriving markets. He will also be identifying new markets where the company’s technology can make huge differences to current practices and efficiencies, also overseeing the expansion of the team as Visionable grows.

Walker has leadership experience in a range of industries, having held senior commercial roles at Sky Television, Dyson, fintech Neyber, and most recently as CCO of AI based technology company Winnow. His experience in creating compelling propositions from innovative products places him in a unique position to understand and deliver on Visionable's current offering and messaging.

Commenting on his new appointment, David Walker said, "I was drawn to Visionable because of the company’s clear dedication to its mission to make healthcare more equitable and accessible for all and its proposition that is changing healthcare as we know it: creating advanced, efficient systems that deliver better outcomes for both patients and professionals."

"Visionable is at an exciting phase of its development, experiencing exceptional demand, poised to scale up and with patented and unique technology to support its vision. I'm delighted to join the Visionable team and be involved in this next stage of the company's growth."

CEO and co-founder of Visionable, Alan Lowe, said, "David has proved his ability, throughout a stellar career, to boost a company’s market share by selling value rather than price, a principle that is intrinsic to Visionable. I’m delighted to welcome David as CCO to our expanding executive team and look forward to working closely with him as we forge partnerships and enter new markets to improve equity in healthcare and deliver better patient outcomes."

About Visionable

Visionable is a healthcare technology company, established in 2015, that provides a digital collaboration platform for clinicians to deliver better patient care. Designed by founders who have worked within the NHS and who continue to partner closely with NHS clinicians, the platform has been created to develop fit-for-purpose digital care pathways and virtual care consultations. Used by NHS hospitals and Trusts, Visionable has delivered and improved patient flow, facilitated quicker decision making and improved patient experience across multiple care settings and specialities such as stroke. This extends to patient consultations, remote diagnostics, telehealth solutions, multidisciplinary teams, virtual visits, and critical patient services.

Most Popular Now

Can Language Models Read the Genome? Thi…

The same class of artificial intelligence that made headlines coding software and passing the bar exam has learned to read a different kind of text - the genetic code. That code...

Bayer and Google Cloud to Accelerate Dev…

Bayer and Google Cloud announced a collaboration on the development of artificial intelligence (AI) solutions to support radiologists and ultimately better serve patients. As part of the collaboration, Bayer will...

Study Shows Human Medical Professionals …

When looking for medical information, people can use web search engines or large language models (LLMs) like ChatGPT-4 or Google Bard. However, these artificial intelligence (AI) tools have their limitations...

Shared Digital NHS Prescribing Record co…

Implementing a single shared digital prescribing record across the NHS in England could avoid nearly 1 million drug errors every year, stopping up to 16,000 fewer patients from being harmed...

North West Anglia Works with Clinisys to…

North West Anglia NHS Foundation Trust has replaced two, legacy laboratory information systems with a single instance of Clinisys WinPath. The trust, which serves a catchment of 800,000 patients in North...

Can AI Techniques Help Clinicians Assess…

Investigators have applied artificial intelligence (AI) techniques to gait analyses and medical records data to provide insights about individuals with leg fractures and aspects of their recovery. The study, published in...

AI Makes Retinal Imaging 100 Times Faste…

Researchers at the National Institutes of Health applied artificial intelligence (AI) to a technique that produces high-resolution images of cells in the eye. They report that with AI, imaging is...

SPARK TSL Acquires Sentean Group

SPARK TSL is acquiring Sentean Group, a Dutch company with a complementary background in hospital entertainment and communication, and bringing its Fusion Bedside platform for clinical and patient apps to...

Standing Up for Health Tech and SMEs: Sh…

AS the new chair of the health and social care council at techUK, Shane Tickell talked to Highland Marketing about his determination to support small and innovative companies, by having...

GPT-4 Matches Radiologists in Detecting …

Large language model GPT-4 matched the performance of radiologists in detecting errors in radiology reports, according to research published in Radiology, a journal of the Radiological Society of North America...

ChatGPT Extracts Data for Ischaemic Stro…

In an ischaemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must...

Experts Propose Specific and Suited Guid…

Current Artificial Intelligence (AI) models for cancer treatment are trained and approved only for specific intended purposes. GMAI models, in contrast, can handle a wide range of medical data including...